Results 61 to 70 of about 11,334,328 (240)

Smaller is better: nanobodies meet NMR

open access: yesFEBS Letters, EarlyView.
Nanobodies are single‐domain antigen‐binding fragments derived from camelid heavy chain antibodies. Their small size, high stability, and exceptional specificity make nanobodies uniquely useful probes for NMR studies of protein dynamics, transient conformational states, and protein–protein interactions.
Oleg Y. Dmitriev
wiley   +1 more source

Thermal performance enhancement in a circular tube with louvered V-winglet inserts: effect of louver angle and opening area

open access: yesCase Studies in Thermal Engineering
This paper presents an evaluation of the thermal performance of a circular tube with louvered V-winglet inserts (LVWs) under turbulent flow conditions.
Anuwat Saenpong   +3 more
doaj   +1 more source

Design Process of a Triple Redundant Fault Tolerant PMA SynRM

open access: yesIEEE Access, 2019
Fault tolerant machine drives are being favored by safety-critical applications. However, the machine needs to be carefully designed since it is required to achieve high performance in healthy condition as well as good fault tolerance for various faults.
Bo Wang, Jiapeng Hu, Wei Hua
doaj   +1 more source

Membrane composition and thermodynamic identity as boundaries of life for synthetic cell research

open access: yesFEBS Letters, EarlyView.
What makes a cell a cell? The boundary of a living cell is not just a wall. Read as a Markov blanket, the membrane separates internal from external states, generating identity and non‐equilibrium order. Can this identity be rebuilt from scratch in a synthetic cell?
Caterina Presutti, Bert Poolman
wiley   +1 more source

Age‐related circulatory responses to whole body cooling: observations by heart rate variability

open access: yesFinnish Journal of eHealth and eWelfare, 2015
The purpose was to study potential age ‐ related changes in the circulatory system via heart rate variability (HRV) by gradually lowering ambient temperature (0.2°C/min) from thermoneutral (32 C°) towards cold (18 C°).
Jarmo Alametsä   +7 more
doaj  

Energy-saving optimization of server multi-fan control system based on weighting mechanism and evolution strategy

open access: yesResults in Control and Optimization
Each server in data centers is equipped with multiple fans and heat-generating components. Factors such as fans speed, layout of components, and loading scenarios, will influence the airflow and thermal flow fields within a server.
Chun-Wei Lan   +3 more
doaj   +1 more source

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

open access: yesMolecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla   +9 more
wiley   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy